vs

Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and GERON CORP (GERN). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $43.5M, roughly 1.1× DYNEX CAPITAL INC). On growth, DYNEX CAPITAL INC posted the faster year-over-year revenue change (531.3% vs 67.1%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 75.8%).

Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

DX vs GERN — Head-to-Head

Bigger by revenue
GERN
GERN
1.1× larger
GERN
$47.2M
$43.5M
DX
Growing faster (revenue YoY)
DX
DX
+464.2% gap
DX
531.3%
67.1%
GERN
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
75.8%
DX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
DX
DX
GERN
GERN
Revenue
$43.5M
$47.2M
Net Profit
$-18.4M
Gross Margin
Operating Margin
-29.4%
Net Margin
-39.0%
Revenue YoY
531.3%
67.1%
Net Profit YoY
30.3%
EPS (diluted)
$1.59
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DX
DX
GERN
GERN
Q4 25
$43.5M
Q3 25
$30.6M
$47.2M
Q2 25
$23.1M
$49.0M
Q1 25
$17.1M
$39.6M
Q3 24
$28.3M
Q2 24
$882.0K
Q1 24
$-3.2M
$304.0K
Q4 23
$23.0K
Net Profit
DX
DX
GERN
GERN
Q4 25
Q3 25
$150.4M
$-18.4M
Q2 25
$-13.6M
$-16.4M
Q1 25
$-3.1M
$-19.8M
Q3 24
$-26.4M
Q2 24
$-67.4M
Q1 24
$40.1M
$-55.4M
Q4 23
Operating Margin
DX
DX
GERN
GERN
Q4 25
Q3 25
-29.4%
Q2 25
-25.4%
Q1 25
-42.2%
Q3 24
-99.8%
Q2 24
-7860.9%
Q1 24
-18465.1%
Q4 23
Net Margin
DX
DX
GERN
GERN
Q4 25
Q3 25
491.3%
-39.0%
Q2 25
-58.8%
-33.4%
Q1 25
-18.0%
-50.1%
Q3 24
-93.5%
Q2 24
-7639.8%
Q1 24
-1256.8%
-18220.4%
Q4 23
EPS (diluted)
DX
DX
GERN
GERN
Q4 25
$1.59
Q3 25
$1.08
$-0.03
Q2 25
$-0.14
$-0.02
Q1 25
$-0.06
$-0.03
Q3 24
$-0.04
Q2 24
$-0.10
Q1 24
$0.64
$-0.09
Q4 23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DX
DX
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$531.0M
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.5B
$248.7M
Total Assets
$17.3B
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DX
DX
GERN
GERN
Q4 25
$531.0M
Q3 25
$491.0M
$78.1M
Q2 25
$387.5M
$77.7M
Q1 25
$327.4M
$83.7M
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$295.7M
$189.8M
Q4 23
$70.0M
Stockholders' Equity
DX
DX
GERN
GERN
Q4 25
$2.5B
Q3 25
$2.0B
$248.7M
Q2 25
$1.6B
$259.5M
Q1 25
$1.4B
$268.2M
Q3 24
$292.3M
Q2 24
$306.7M
Q1 24
$958.5M
$344.9M
Q4 23
$247.9M
Total Assets
DX
DX
GERN
GERN
Q4 25
$17.3B
Q3 25
$14.2B
$567.4M
Q2 25
$11.3B
$555.2M
Q1 25
$9.0B
$562.5M
Q3 24
$444.9M
Q2 24
$449.4M
Q1 24
$6.3B
$482.1M
Q4 23
$394.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DX
DX
GERN
GERN
Operating Cash FlowLast quarter
$120.8M
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DX
DX
GERN
GERN
Q4 25
$120.8M
Q3 25
$68.3M
$-13.6M
Q2 25
$31.9M
$-27.4M
Q1 25
$6.4M
$-48.0M
Q3 24
$-58.9M
Q2 24
$-53.5M
Q1 24
$-17.1M
$-62.3M
Q4 23
$-167.7M
Free Cash Flow
DX
DX
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
Q4 23
$-168.6M
FCF Margin
DX
DX
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Q4 23
-732926.1%
Capex Intensity
DX
DX
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Q4 23
3608.7%
Cash Conversion
DX
DX
GERN
GERN
Q4 25
Q3 25
0.45×
Q2 25
Q1 25
Q3 24
Q2 24
Q1 24
-0.43×
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons